miR-205-5p Mediated Downregulation of PTEN Contributes to Cisplatin Resistance in C13K Human Ovarian Cancer Cells

被引：39
作者：
Shi, Xiaoyan [1 ,3 ]
Xiao, Lan [4 ]
Mao, Xiaolu [5 ]
He, Jinrong [1 ,3 ]
Ding, Yu [1 ,3 ]
Huang, Jin [1 ,3 ]
Peng, Caixia [1 ,3 ]
Xu, Zihui [1 ,2 ]
机构：
[1] Huazhong Univ Sci & Technol, Cent Hosp Wuhan, Tongji Med Coll, Key Lab Mol Diag Hubei Prov, Wuhan, Hubei, Peoples R China
[2] Wuhan Univ, Renmin Hosp, Dept Endocnnol & Metab, Wuhan, Hubei, Peoples R China
[3] Huazhong Univ Sci & Technol, Cent Hosp Wuhan, Tongji Med Coll, Cent Lab, Wuhan, Hubei, Peoples R China
[4] An Hui Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Hefei, Anhui, Peoples R China
[5] Huazhong Univ Sci & Technol, Cent Hosp Wuhan, Tongii Med Coll, Dept Clin Lab, Wuhan, Hubei, Peoples R China
来源：
FRONTIERS IN GENETICS | 2018年 / 9卷
基金：
中国国家自然科学基金;
关键词：
miR-205-5p; PTEN; cisplatin resistance; ovarian cancer; AKT; PANCREATIC-CANCER; INDUCED APOPTOSIS; TARGETING PTEN; LUNG-CANCER; INHIBITION; EXPRESSION; CARCINOMA; PATHWAY; LEADS;
D O I：
10.3389/fgene.2018.00555
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
Cisplatin resistance is a major cause of treatment failure in advanced ovarian cancer. The limited evidence shows the paradoxical regulation of miR-205 on chemotherapy resistance in cancer. Herein, we found that miR-205-5p was enormously increased in cisplatin-resistant C13K ovarian cancer cells compared with its cisplatin-sensitive OV2008 parental cells using miRNA microarrays, which was further verified by quantitative PCR. Furthermore, we confirmed that inhibition of miR-205-5p upregulated PTEN and subsequently attenuated its downstream target p-AKT, which inversed C13K cells from cisplatin resistance to sensitivity. Our data suggest that miR-205-5p contributes to cisplatin resistance in C13K ovarian cancer cells may via targeting PTEN/AKT pathway.
引用
收藏
页数：8
相关论文
共 30 条
  • [1] E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitry
    Alla, Vijay
    Kowtharapu, Bhavani S.
    Engelmann, David
    Emmrich, Stephan
    Schmitz, Ulf
    Steder, Marc
    Puetzer, Brigitte M.
    [J]. CELL CYCLE, 2012, 11 (16) : 3067 - 3078
  • [2] Asselin E, 2001, CANCER RES, V61, P1862
  • [3] A miRNA Signature of Chemoresistant Mesenchymal Phenotype Identifies Novel Molecular Targets Associated with Advanced Pancreatic Cancer
    Bera, Alakesh
    VenkataSubbaRao, Kolaparthi
    Manoharan, Muthu Saravanan
    Hill, Ping
    Freeman, James W.
    [J]. PLOS ONE, 2014, 9 (09):
  • [4] Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells
    Bhatnagar, N.
    Li, X.
    Padi, S. K. R.
    Zhang, Q.
    Tang, M-S
    Guo, B.
    [J]. CELL DEATH & DISEASE, 2010, 1 : e105 - e105
  • [5] miR-205 Targets PTEN and PHLPP2 to Augment AKT Signaling and Drive Malignant Phenotypes in Non-Small Cell Lung Cancer
    Cai, Junchao
    Fang, Lishan
    Huang, Yongbo
    Li, Rong
    Yuan, Jie
    Yang, Yi
    Zhu, Xun
    Chen, Baixue
    Wu, Jueheng
    Li, Mengfeng
    [J]. CANCER RESEARCH, 2013, 73 (17) : 5402 - 5415
  • [6] New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase AKT pathway
    Cantley, LC
    Neel, BG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) : 4240 - 4245
  • [7] Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205
    Chaudhary, Amit Kumar
    Mondal, Goutam
    Kumar, Virender
    Kattel, Krishna
    Mahato, Ram I.
    [J]. CANCER LETTERS, 2017, 402 : 1 - 8
  • [8] miR-205 regulates the proliferation and invasion of ovarian cancer cells via suppressing PTEN/SMAD4 expression
    Chu, Ping
    Liang, Aihua
    Jiang, Aili
    Zong, Lu
    [J]. ONCOLOGY LETTERS, 2018, 15 (05) : 7571 - 7578
  • [9] miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance
    De Cola, A.
    Volpe, S.
    Budani, M. C.
    Ferracin, M.
    Lattanzio, R.
    Turdo, A.
    D'Agostino, D.
    Capone, E.
    Stassi, G.
    Todaro, M.
    Di Ilio, C.
    Sala, G.
    Piantelli, M.
    Negrini, M.
    Veronese, A.
    De laurenzi, V.
    [J]. CELL DEATH & DISEASE, 2015, 6 : e1823 - e1823
  • [10] Systems biology of cisplatin resistance: past, present and future
    Galluzzi, L.
    Vitale, I.
    Michels, J.
    Brenner, C.
    Szabadkai, G.
    Harel-Bellan, A.
    Castedo, M.
    Kroemer, G.
    [J]. CELL DEATH & DISEASE, 2014, 5 : e1257 - e1257
123